Shared on 30 Oct 25
Encompass Health's analyst price target has been increased by $10 to $150. Analysts cite strong discharge growth and ongoing expansion strategies as key factors supporting the upward revision.
Shared on 15 Oct 25
Fair value Increased 1.21%Aging Population And Hospital Openings Will Drive Patient Demand
Encompass Health's analyst price target has increased by $1.67 to $139.08. Analysts cite the company's ongoing strong discharge growth and expansion strategies as key drivers for the upward revision.
Shared on 20 Sep 25
Fair value Increased 1.23%Aging Population And Hospital Openings Will Drive Patient Demand
With both future P/E and net profit margin remaining effectively unchanged, Encompass Health’s consensus analyst price target saw only a marginal increase from $135.75 to $137.42. What's in the News The New York Times reports Encompass Health, a leading rehab hospital operator, has had incidents of patient harm and underperforms on some Medicare safety measures, notably with higher unplanned readmissions, though it excels at helping patients return home; regulatory action and disclosure appear limited.
Shared on 05 Sep 25
Aging Population And Hospital Openings Will Drive Patient Demand
With both Net Profit Margin and Consensus Revenue Growth forecasts holding steady, analysts have kept their price target for Encompass Health unchanged at $135.75. What's in the News The New York Times reports that Encompass Health, a dominant for-profit rehab hospital operator, has had rare but serious incidents of patient harm and performs below average on certain Medicare safety measures, including high rates of unplanned readmissions, though it generally excels in helping patients return and stay home; federal enforcement and transparency are deemed limited (NY Times, 2025-07-15).
Shared on 07 May 25
Fair value Increased 6.27%Aging Population And Hospital Openings Will Drive Patient Demand
Shared on 30 Apr 25
Fair value Increased 5.46%New Beds And CMS Updates Will Improve Inpatient Care
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 23 Apr 25
Fair value Increased 0.62%New Beds And CMS Updates Will Improve Inpatient Care
AnalystConsensusTarget has decreased shares outstanding growth rate from 0.0% to -0.0%.
Shared on 17 Apr 25
Fair value Increased 0.94%New Beds And CMS Updates Will Improve Inpatient Care
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
New Beds And CMS Updates Will Improve Inpatient Care
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
Fair value Increased 2.51%New Beds And CMS Updates Will Improve Inpatient Care
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
New Beds And CMS Updates Will Improve Inpatient Care
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 19 Mar 25
Fair value Decreased 9.09%New Beds And CMS Updates Will Improve Inpatient Care
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 10 Mar 25
Fair value Decreased 2.75%New Beds And CMS Updates Will Improve Inpatient Care
AnalystConsensusTarget made no meaningful changes to valuation assumptions.